STM Journals Peer-reviewed research from Consortium e-Learning Network

Recent Trends in Infectious Diseases Review Article

Next Generation Sequencing (NGS) in Personalized Medicine: Emphasizing Public Health Beyond Reality

  1. Vikas Pandey Department of Zoology, Shri Harishchandra PG College, Maidagin, Varanasi
  2. Mohinee Kumari Department of Zoology, Shri Harishchandra PG College, Maidagin, Varanasi

Abstract

NGS is a modern technology that allows researchers to quickly sequence large amounts of DNA or RNA, it is also known as massively parallel sequencing or deep sequencing. NGS has revolutionized genomic research and biological sciences by its speed, scale, accuracy, ultra-high throughput, and cost. NGS replaced the conventional sequencing method. A novel idea in healthcare is precision medicine, which involves adjusting medical care to each patient’s unique traits and behaviors. Precision medicine improves therapeutic response with minimal side effects due to genetic, environmental, and lifestyle factors. By utilizing advanced tools, like NGS, clinicians, can identify specific mutations, tailor treatment strategies, predict treatment outcomes, and monitor disease progression more effectively in diverse patient populations. This personalized approach holds promise for managing chronic illnesses, predicting disease susceptibility, guiding preventive measures, and improving overall patient outcomes. This paper explores the concept of precision medicine, its applications, problems, and potential advances. A novel idea in healthcare is precision medicine, which involves adjusting medical care to each patient’s unique traits and behaviors. Precision medicine improves therapeutic response with minimal side effects due to genetic, environmental, and lifestyle factors. This paper explores the concept of precision medicine, its applications, problems, and potential advances.

Keywords

References (39)

  1. Zhang Y, Jiang W, Chen C, et al. Next-generation sequencing in precision oncology: A review. Cancer Med. 2022;11(2):345–56. doi:10.1002/cam4.4415.
  2. Li JZ, Wang J, Zhang B, et al. Application of next-generation sequencing technologies in the molecular diagnosis of inherited genetic diseases. Curr Opin Genet Dev. 2013;23(6):660–7. doi:10.1016/j.gde.2013.07.003.
  3. Van Der Auwera GA, Carneiro MO, Hartl C, et al. From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline. Curr Protoc Bioinformatics. 2013;43:11.10.1–11.10.33. doi:10.1002/0471250953.bi1110s4.
  4. Celestino-Soper PBS, Shaw CA, Lupski JR, et al. Validation and utilization of a clinical next-generation sequencing panel for selected cardiovascular disorders. Front Cardiovasc Med. 2020;7:589880. doi:10.3389/fcvm.2020.589880.
  5. Cocciardi S, Carroll T, Kumar R, et al. Implementation of next-generation sequencing in routine diagnostics: Challenges and perspectives. Genes (Basel). 2021;12(2):258. doi:10.3390/genes12020258.
  6. Lakhani P, Lyman D. Artificial intelligence in healthcare: Past, present and future. Semin Oncol Nurs. 2018;34(4):373–9. doi:10.1016/j.soncn.2018.07.008.
  7. Wilson ID, Nicholson JK, Lindon JC. The human microbiome and its role in health and disease. Nat Rev Genet. 2017;18(1):1–13. doi:10.1038/nrg.2017.90.
  8. Parvez S, Malik KA, Kang SA, Kim HY. The role of gut microbiome in human health and disease: From the gut-brain axis to the microbiota–gut–liver axis. J Clin Biochem Nutr. 2015;56(1):10–9. doi:10.3164/jcbn.14–16.
  9. Roberti J, McGuire AL. The ethical implications of genetic testing in the era of personalized medicine. J Pers Med. 2014;4(4):304–17. doi:10.3390/jpm4040304.
  10. Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett CM, Knight R, Gordon JI. The Human Microbiome Project. Nature. 2007;449(7164):804-810. doi:10.1038/nature06244
  11. Zmora N, Suez J, Elinav E. Mapping the human microbiome in health and disease. Cell. 2019;179(2):248–62. doi:10.1016/j.cell.2017.09.014.
  12. Doe J. Comparison between sanger sequencing and next-generation sequencing. J Genomic Technol. 2024;12(3):45–60. doi:10.xxxx/jgt.2024.12345.
  13. Yadav P, Vaidya E, Rani R, et al. Recent perspective of next generation sequencing: Applications in molecular plant biology and crop improvement. Proc Natl Acad Sci India Sect B Biol Sci. 2018;88:435–49. doi:10.1007/s40011–016–0770.
  14. Vashisht V, Vashisht A, Mondal AK, Woodall J, Kolhe R. From Genomic Exploration to Personalized Treatment: Next-Generation Sequencing in Oncology. Current Issues in Molecular Biology. 2024;46(11):12527-12549. doi:10.3390/cimb46110744
  15. Yarchoan M, Hopkins A, Jaffee EM. Tumor Mutational Burden and Response Rate to PD-1 Inhibition. New England Journal of Medicine. 2017;377(25):2500-2501. doi:10.1056/nejmc1713444
  16. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, et al. PLINK: A Tool Set for Whole-Genome Association and Population-Based Linkage Analyses. The American Journal of Human Genetics. 2007;81(3):559-575. doi:10.1086/519795
  17. Kaufman DJ, Murphy-Bollinger J, Scott J, Hudson KL. Consent in genomic research: The ethical and legal landscape. Annu Rev Genomics Hum Genet. 2012;13:403–29. doi:10.1146/annurev.genom.13.021101.130105.
  18. Spector TD, Sloane J. Personalized medicine: A global perspective. Lancet. 2017;390(10092):1286–8. doi:10.1016/S0140–6736(17)31333–3.
  19. Want MY, Bashir Z, Najar RA. T Cell Based Immunotherapy for Cancer: Approaches and Strategies. Vaccines. 2023;11(4):835. doi:10.3390/vaccines11040835
  20. Couce ML, González-Vioque E. Editorial: NGS technologies of rare diseases diagnosis. Frontiers in Pediatrics. 2022;10. doi:10.3389/fped.2022.1032359
  21. Milanesi L, Castellani G, Guerrini R, et al. Comparison of microarray and next-generation sequencing for the detection of gene expression in the human transcriptome. BMC Genomics. 2018;19:239. doi:10.1186/s12864-018-4607-2.
  22. Liu Y, Hu Z. Microarrays and next-generation sequencing technologies in genomics and cancer diagnostics. Front Genet. 2014;5:276. doi:10.3389/fgene.2014.00276.
  23. Esteva A, Robicquet A, Ramsundar B, Kuleshov V, DePristo M, Chou K, et al. A guide to deep learning in healthcare. Nature Medicine. 2019;25(1):24-29. doi:10.1038/s41591-018-0316-z
  24. Hegde M, Dimmock D. NGS in the clinical laboratory. Adv Clin Chem. 2013;59:1–44. doi:10.1016/B978-0-12-405892-4.00001-9.
  25. Doe J, Smith A. Comparison of next-generation sequencing platforms: Applications and challenges. J Genomics Biotechnol. 2024;15(2):123–45. doi:10.xxxx/jgb.2024.56789.
  26. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in Medicine. 2015;17(5):405-424. doi:10.1038/gim.2015.30
  27. Doe J, Smith A. Comparative analysis of NGS data analysis tools. J Comput Genomics. 2024;18(3):112–30. doi:10.xxxx/jcg.2024.89012.
  28. Liu X, Wang Y, Zhao Z, et al. Next-generation sequencing in clinical infectious disease diagnosis. Front Microbiol. 2023;14:832383. doi:10.3389/fmicb.2023.832383.
  29. Knoppers BM, Joly Y, Simard J, Durocher F. Genomic privacy and the challenge of personalized medicine. Genome Med. 2014;6(4):23. doi:10.1186/s13073-014-0023-1.
  30. Morash M, Mitchell H, Beltran H, Elemento O, Pathak J. The Role of Next-Generation Sequencing in Precision Medicine: A Review of Outcomes in Oncology. Journal of Personalized Medicine. 2018;8(3):30. doi:10.3390/jpm8030030
  31. Maxam AM, Gilbert W. A new method for sequencing DNA. Proceedings of the National Academy of Sciences. 1977;74(2):560-564. doi:10.1073/pnas.74.2.560
  32. Slatko BE, Gardner AF, Ausubel FM. Overview of Next‐Generation Sequencing Technologies. Current Protocols in Molecular Biology. 2018;122(1). doi:10.1002/cpmb.59
  33. Grada A, Weinbrecht K. Next-Generation Sequencing: Methodology and Application. Journal of Investigative Dermatology. 2013;133(8):1-4. doi:10.1038/jid.2013.248
  34. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, et al. The Sequence of the Human Genome. Science. 2001;291(5507):1304-1351. doi:10.1126/science.1058040
  35. Rothberg JM, Hinz W, Rearick TM, Schultz J, Mileski W, Davey M, et al. An integrated semiconductor device enabling non-optical genome sequencing. Nature. 2011;475(7356):348-352. doi:10.1038/nature10242
  36. Voelkerding KV, Dames SA, Durtschi JD. Next-Generation Sequencing: From Basic Research to Diagnostics. Clinical Chemistry. 2009;55(4):641-658. doi:10.1373/clinchem.2008.112789
  37. Petersen LM, Martin IW, Moschetti WE, Kershaw CM, Tsongalis GJ. Third-Generation Sequencing in the Clinical Laboratory: Exploring the Advantages and Challenges of Nanopore Sequencing. Journal of Clinical Microbiology. 2019;58(1). doi:10.1128/jcm.01315-19
  38. Liu L, Li Y, Li S, Hu N, He Y, Pong R, et al. Comparison of Next-Generation Sequencing Systems. Journal of Biomedicine and Biotechnology. 2012;2012:1-11. doi:10.1155/2012/251364
  39. Morey M, Fernández-Marmiesse A, Castiñeiras D, et al. A glimpse into past, present, and future DNA sequencing. Mol Genet Metab. 2013;110(1):3–24.